Literature DB >> 26357990

Associations of diabetes mellitus with orthopaedic infections.

Mohamed Al-Mayahi1, Anais Cian1, Benjamin Kressmann1,2, Benedicte de Kalbermatten3, Peter Rohner4, Michael Egloff3, Jafaar Jafaar3, Sarah Malacarne3, Hermes H Miozzari1, Ilker Uçkay1,2.   

Abstract

BACKGROUND: Clinical experience suggests that a high proportion of orthopaedic infections occur in persons with diabetes.
METHODS: We reviewed several databases of adult patients hospitalized for orthopaedic infections at Geneva University Hospitals from 2004 to 2014 and retrieved 2740 episodes of infection.
RESULTS: Overall, diabetes was noted in the medical record for 659 (24%) of these cases. The patients with, compared with those without, diabetes had more than five times more foot infections (274/659 [42%] vs 155/2081 [7%]; p < 0.01) and a significantly higher serum C-reactive protein level at admission (median 96 vs 70 mg/L; p < 0.01). Diabetic patients were older (median 67 vs 52 years; p < 0.01), more often male (471 [71%] vs 1398 [67%]; p = 0.04), and had more frequent polymicrobial infections (219 [37%] vs 353 [19%]; p < 0.01), including more gram-negative non-fermenting rods (90 [15%] vs 168 [9%]; p < 0.01). Excluding foot infections from these analyses did not change the statistically significant differences. Diabetes was present in 17% of all infected orthopaedic patients without foot involvement. In Geneva canton, the overall prevalence of diabetes is estimated at 5.1%, while we have found that the prevalence is 13% in our hospitalized adults.
CONCLUSIONS: Diabetes is present in 24% of all adult patients hospitalized for surgery for an orthopaedic infection, a prevalence that is several times higher than for the general population and twice as high as that for the population of hospitalized patients. Compared with non-diabetics, patients with diabetes have significantly more infections that are polymicrobial, including gram-negative non-fermenting rods.

Entities:  

Keywords:  Diabetes mellitus; association; epidemiology; infection; orthopaedic

Mesh:

Substances:

Year:  2015        PMID: 26357990     DOI: 10.3109/23744235.2015.1082620

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  6 in total

1.  Which Orthopaedic Patients Are Infected with Gram-negative Non-fermenting Rods?

Authors:  Omid Jamei; Shpresa Gjoni; Besa Zenelaj; Benjamin Kressmann; Wilson Belaieff; Didier Hannouche; Ilker Uçkay
Journal:  J Bone Jt Infect       Date:  2017-01-15

2.  Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study.

Authors:  Cristiana M Toscano; Tatiana H Sugita; Michelle Q M Rosa; Hermelinda C Pedrosa; Roger Dos S Rosa; Luciana R Bahia
Journal:  Int J Environ Res Public Health       Date:  2018-01-08       Impact factor: 3.390

3.  Changing perioperative prophylaxis during antibiotic therapy and iterative debridement for orthopedic infections?

Authors:  Lydia Wuarin; Mohamed Abbas; Stephan Harbarth; Felix Waibel; Dominique Holy; Jan Burkhard; Ilker Uçkay
Journal:  PLoS One       Date:  2019-12-18       Impact factor: 3.240

4.  Short postsurgical antibiotic therapy for spinal infections: protocol of prospective, randomized, unblinded, noninferiority trials (SASI trials).

Authors:  Michael Betz; Ilker Uçkay; Regula Schüpbach; Tanja Gröber; Sander M Botter; Jan Burkhard; Dominique Holy; Yvonne Achermann; Mazda Farshad
Journal:  Trials       Date:  2020-02-06       Impact factor: 2.279

Review 5.  Short and oral antimicrobial therapy for diabetic foot infection: a narrative review of current knowledge.

Authors:  Steven M Maurer; Zehra S Hepp; Shawna McCallin; Felix W A Waibel; Federico C Romero; Yılmaz Zorman; Benjamin A Lipsky; İlker Uçkay
Journal:  J Bone Jt Infect       Date:  2022-03-25

6.  Correction of hyperglycemia after surgery for diabetic foot infection and its association with clinical outcomes.

Authors:  Céline S Moret; Madlaina Schöni; Felix W A Waibel; Elin Winkler; Angelina Grest; Bettina S Liechti; Jan Burkhard; Dominique Holy; Martin C Berli; Benjamin A Lipsky; Ilker Uçkay
Journal:  BMC Res Notes       Date:  2022-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.